ANIK vs RTX · rev $62.2M vs P/E 36, rev $46.78B
Anika Therapeutics Inc (ANIK) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
ANIK currently screens at market cap $161.3M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the ANIK and RTX stock pages for the full models.
Not investment advice.